Silodosin, a novel selective alpha 1A-adrenoceptor selective antagonist for the treatment of benign prostatic hyperplasia.

Silodosin, a novel selective alpha 1A-adrenoceptor selective antagonist for the treatment of benign prostatic hyperplasia.

Item
http://www.wikidata.org/entity/Q34585420
Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient acceptabilitySilodosin for benign prostatic hyperplasia.Silodosin in the treatment of benign prostatic hyperplasiaSilodosin in the treatment of the signs and symptoms of benign prostatic hyperplasia: profile report.Silodosin for the treatment of benign prostatic hyperplasia: pharmacology and cardiovascular tolerability.Silodosin: treatment of the signs and symptoms of benign prostatic hyperplasia.Silodosin: a review of its use in the treatment of the signs and symptoms of benign prostatic hyperplasia.Evaluation of silodosin in comparison to tamsulosin in benign prostatic hyperplasia: a randomized controlled trial.Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH.Short-term effects of crossover treatment with silodosin and tamsulosin hydrochloride for lower urinary tract symptoms associated with benign prostatic hyperplasia.Design of phosphorus ligands with deep chiral pockets: practical synthesis of chiral β-arylamines by asymmetric hydrogenation.Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.Urethral Sensations are Related to the Development of Detrusor Overactivity.Determination of silodosin and its active glucuronide metabolite KMD-3213G in human plasma by LC-MS/MS for a bioequivalence study.Excitatory effect of propiverine hydrochloride on urethral activity in rats.Randomized Crossover Comparison of the Short-Term Efficacy and Safety of Single Half-Dose Silodosin and Tamsulosin Hydrochoride in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
P2860

Silodosin, a novel selective alpha 1A-adrenoceptor selective antagonist for the treatment of benign prostatic hyperplasia.

Item
http://www.wikidata.org/entity/Q34585420
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Silodosin, a novel selective a ...... benign prostatic hyperplasia.
@ast
Silodosin, a novel selective a ...... benign prostatic hyperplasia.
@en
Silodosin, a novel selective a ...... benign prostatic hyperplasia.
@nl
type
label
Silodosin, a novel selective a ...... benign prostatic hyperplasia.
@ast
Silodosin, a novel selective a ...... benign prostatic hyperplasia.
@en
Silodosin, a novel selective a ...... benign prostatic hyperplasia.
@nl
prefLabel
Silodosin, a novel selective a ...... benign prostatic hyperplasia.
@ast
Silodosin, a novel selective a ...... benign prostatic hyperplasia.
@en
Silodosin, a novel selective a ...... benign prostatic hyperplasia.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Silodosin, a novel selective a ...... benign prostatic hyperplasia.
@en
P2093
P2860
P304
P31
P356
10.1517/13543784.16.12.1955
P407
P433
P478
P577
P698